These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1375694)
21. Human anti-pneumococcal polysaccharide antibodies are secreted by the CD5- B cell lineage. Barrett DJ; Sleasman JW; Schatz DA; Steinitz M Cell Immunol; 1992 Aug; 143(1):66-79. PubMed ID: 1377990 [TBL] [Abstract][Full Text] [Related]
22. Coelomic and bone marrow-derived B cells. Developmental constraints versus antigen-specific selection. Marcos MA; Malenchere E; Sundblad A; Huetz F; Grandien A; Martinez C; Coutinho A Ann N Y Acad Sci; 1992 May; 651():433-42. PubMed ID: 1376059 [No Abstract] [Full Text] [Related]
23. The efficiency of antibody affinity maturation: can the rate of B-cell division be limiting? Manser T Immunol Today; 1990 Sep; 11(9):305-8. PubMed ID: 2206275 [TBL] [Abstract][Full Text] [Related]
24. Increased CD5-positive B lymphocytes in type I diabetes. Muñoz A; Gallart T; Viñas O; Gomis R Clin Exp Immunol; 1991 Feb; 83(2):304-8. PubMed ID: 1704297 [TBL] [Abstract][Full Text] [Related]
25. Seppuku and autoimmunity. Honjo T Science; 1992 Oct; 258(5082):591-2. PubMed ID: 1384132 [No Abstract] [Full Text] [Related]
26. Low molecular weight IgM and CD5 B lymphocytes in rheumatoid arthritis. Xu H; Geddes R; Roberts-Thomson PJ Ann Rheum Dis; 1994 Jun; 53(6):383-90. PubMed ID: 7518662 [TBL] [Abstract][Full Text] [Related]
27. Loss of CD23 is a consequence of B-cell activation. Implications for the analysis of B-cell lineages. Rabin E; Cong YZ; Wortis HH Ann N Y Acad Sci; 1992 May; 651():130-42. PubMed ID: 1376028 [TBL] [Abstract][Full Text] [Related]
28. Somatic mutations in the VH genes of high-affinity antibodies to self and foreign antigens produced by human CD5+ and CD5- B lymphocytes. Ikematsu H; Harindranath N; Casali P Ann N Y Acad Sci; 1992 May; 651():319-27. PubMed ID: 1376051 [No Abstract] [Full Text] [Related]
29. Ly-1 B-lineage cells downregulate the number and proliferation of B-cell precursors. Kruger MG; Riley R; Elia J Ann N Y Acad Sci; 1992 May; 651():170-2. PubMed ID: 1376035 [No Abstract] [Full Text] [Related]
30. Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals. Yi Q; Ahlberg R; Pirskanen R; Lefvert AK Neurology; 1992 May; 42(5):1081-4. PubMed ID: 1374547 [TBL] [Abstract][Full Text] [Related]
31. CD5+ B cells predominate in peripheral tissues of rabbit. Raman C; Knight KL J Immunol; 1992 Dec; 149(12):3858-64. PubMed ID: 1281192 [TBL] [Abstract][Full Text] [Related]
32. Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg). Vassilev T; Gelin C; Kaveri SV; Zilber MT; Boumsell L; Kazatchkine MD Clin Exp Immunol; 1993 Jun; 92(3):369-72. PubMed ID: 7685668 [TBL] [Abstract][Full Text] [Related]
33. Receptor editing during affinity maturation. George AJ; Gray D Immunol Today; 1999 Apr; 20(4):196. PubMed ID: 10203719 [No Abstract] [Full Text] [Related]
34. The frequency of CD5+ B lymphocytes in the peripheral blood of patients with myasthenia gravis. Ragheb S; Lisak RP Neurology; 1990 Jul; 40(7):1120-4. PubMed ID: 1694020 [TBL] [Abstract][Full Text] [Related]
35. Effect of age on the expressed B cell repertoire: role of B cell subsets. Hu A; Ehleiter D; Ben-Yehuda A; Schwab R; Russo C; Szabo P; Weksler ME Int Immunol; 1993 Sep; 5(9):1035-9. PubMed ID: 7694639 [TBL] [Abstract][Full Text] [Related]
36. The relationship between circulating CD5+ B lymphocytes and in vitro autoantibody synthesis in normal individuals. Jasin HE Cell Immunol; 1991 Aug; 136(1):133-41. PubMed ID: 1711929 [TBL] [Abstract][Full Text] [Related]
37. Specificity and idiotope expression of IgM produced by CD5+ and CD5- cord blood B-cell clones. Lydyard PM; MacKenzie LE; Youinou PY; Deane M; Jefferis R; Mageed RA Ann N Y Acad Sci; 1992 May; 651():527-39. PubMed ID: 1376073 [TBL] [Abstract][Full Text] [Related]
38. Effect of clinical status and treatment on the frequency of CD5+ B cells in patients with myasthenia gravis. Ragheb S; Lisak RP Neurology; 1992 May; 42(5):1076-80. PubMed ID: 1374546 [TBL] [Abstract][Full Text] [Related]
39. Expression of activated molecules on CD5(+)B lymphocytes in autoimmune hemolytic anemia. Zhu H; Xu W; Liu H; Wang H; Fu R; Wu Y; Qu W; Wang G; Guan J; Song J; Xing L; Shao Z Int J Hematol; 2016 May; 103(5):545-53. PubMed ID: 26968550 [TBL] [Abstract][Full Text] [Related]
40. CD5 expression is modulated as the B cell moves through the cell cycle. Brooks KH; Yol YS; Pestka JJ Ann N Y Acad Sci; 1992 May; 651():259-60. PubMed ID: 1376044 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]